By Christy Santhosh May 28 (Reuters) - The U.S. FDA's advisory panel will meet and then vote on Thursday on whether COVID-19 ...
The FDA is meeting later this week to decide which variant the 2026-27 COVID vaccine will target. The WHO recommended ...
Experts clarify the true symptoms of the NB.1.8.1 COVID-19 variant amid circulating misinformation. Read more at straitstimes ...
The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the ...
An overview of the recent rise in Covid-19 cases, testing positivity rates, and advice on vaccination. Read more at ...
Dealing with a persistent cough and sore throat that seems to worsen over time? You might have the dreaded "razor blade throat," thought to be a symptom of new COVID variant, NB 1.8.1. Here's ...
A highly transmissible new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States. The mutated omicron subvariant, which is known for causing a painful symptom dubbed ...
Delaware's overall COVID-19 cases are decreasing – there were 5,225 reported COVID-19 cases this season, according to the Delaware Department of Health and Social Services – even as a new variant, ...
The World Health Organisation recently evaluated NB.1.8.1 as a “low risk” variant overall. That classification reflects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results